SRL
PACB icon

Scientech Research LLC’s Pacific Biosciences PACB Stock Holding History

Scientech Research LLC’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.8K Sell
38,450
-214,437
-85% -$384K 0.04% 409
2025
Q4 		$473K Buy
+252,887
New +$486K 0.3% 98
2025
Q1 		– Sell
-10,688
Closed -$19.6K – 749
2024
Q4 		$19.6K Buy
+10,688
New +$20.9K 0.01% 534

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Scientech Research LLC's PACB Position: Q1 2026 in Review

Scientech Research LLC reduced its Pacific Biosciences (PACB) stake by 85% in Q1 2026, selling an estimated $384K and leaving 38,450 shares worth $50.8K. The position accounts for 0.04% of the portfolio, ranked #409.

Scientech Research LLC first reported a position in PACB in Q4 2024 and has held it in 3 quarters since. The position peaked at $473K in Q4 2025. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • Scientech Research LLC held 38,450 shares of Pacific Biosciences worth $50.8K as of Q1 2026.
  • Scientech Research LLC sold 214,437 Pacific Biosciences shares in Q1 2026, an estimated $384K.
  • Pacific Biosciences made up 0.04% of Scientech Research LLC's portfolio in Q1 2026, its #409 holding.
  • Scientech Research LLC first reported a position in Pacific Biosciences in Q4 2024 and has held it in 3 quarters since.
  • Scientech Research LLC's Pacific Biosciences position peaked at $473K in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.